Myopia Management in Hillsborough, NJ
Myopia — commonly known as nearsightedness — is one of the fastest-growing health conditions worldwide. The World Health Organization projects that half of the global population will be myopic by 2050. What was once considered a minor inconvenience correctable with glasses is now understood to be a progressive eye disease: the higher the myopia, the greater the lifetime risk of retinal detachment, glaucoma, macular degeneration, and cataracts. At Amwell Eye Care, Dr. Adam Zhao offers evidence-based myopia management strategies designed to slow the progression of myopia in children and reduce their risk of serious eye disease in adulthood.
What Is Myopia and Why Does It Progress?
Myopia occurs when the eye grows too long from front to back, causing light to focus in front of the retina rather than directly on it. This results in clear near vision but blurry distance vision. Once myopia begins — typically between ages 6 and 14 — the eye continues to elongate and the prescription worsens, often rapidly, through the teenage years.
The primary drivers of myopia onset and progression are:
- Genetics — if one parent is myopic, a child has a 3x higher risk; if both parents are myopic, the risk increases to 6x
- Near work and screen time — sustained close-up activity increases the demand on the focusing system and is associated with faster axial elongation
- Reduced outdoor time — outdoor light exposure is one of the most strongly protective factors against myopia onset; children who spend less time outdoors develop myopia earlier and progress faster
- Early onset — children who become myopic before age 10 are at significantly higher risk of high myopia by adulthood than those who develop it in their teens
Standard glasses and contact lenses correct blurry vision but do nothing to slow the underlying axial elongation. Myopia management treatments actively work to reduce the rate at which the eye grows.
Why Myopia Management Matters Beyond Clear Vision
Each additional diopter of myopia meaningfully increases lifetime risk of serious eye disease:
- Retinal detachment — risk increases 3x at -3.00D and up to 22x at -6.00D compared to non-myopic individuals
- Myopic macular degeneration — a leading cause of irreversible vision loss in high myopes, caused by stretching and thinning of the retina
- Glaucoma — myopes have 2–3x higher risk; the optic nerve is more vulnerable to pressure-related damage in elongated eyes
- Cataracts — nuclear cataracts develop earlier and at higher rates in myopic eyes
Slowing progression by even one diopter significantly reduces these lifetime risks. This is why starting myopia management early — ideally at first diagnosis — makes such a meaningful difference to a child’s long-term eye health.
Myopia Management Options at Amwell Eye Care
Dr. Zhao offers all major evidence-based myopia management treatments and will recommend the most appropriate option based on your child’s age, prescription, lifestyle, and rate of progression:
Orthokeratology (Ortho-K)
Orthokeratology is the gold standard myopia management treatment for most children and young adults. Custom-designed rigid gas-permeable lenses are worn overnight while sleeping. They gently and temporarily reshape the cornea so that the patient wakes up with clear, unaided vision throughout the day — no glasses or contacts needed during waking hours. Beyond the convenience, Ortho-K has strong clinical evidence for slowing axial elongation by 30–60% compared to standard glasses. It is FDA-cleared, reversible, and suitable for children as young as 6. Dr. Zhao has extensive experience fitting Ortho-K lenses and managing patients through their myopia control journey.
MiSight Daily Soft Contact Lenses
MiSight 1 day (CooperVision) is the first and only FDA-approved soft contact lens specifically indicated for myopia management in children aged 8–12 at initiation. These daily disposable lenses use a dual-focus ActivControl design — a central correction zone surrounded by treatment zones that reduce peripheral defocus, the signal thought to drive axial eye growth. Clinical trials show MiSight slows myopia progression by an average of 59% and axial elongation by 52% compared to standard single-vision lenses. MiSight is a particularly good option for younger children or those who are not yet ready for Ortho-K.
Other Dual-Focus and Peripheral Defocus Soft Lenses
Beyond MiSight, several other myopia control soft lens designs are available including NaturalVue Multifocal and extended depth-of-focus lenses. Dr. Zhao will select the most appropriate design based on your child’s prescription, eye shape, and wearing preferences.
Atropine Eye Drops
Low-dose atropine (0.01%–0.05%) eye drops are prescribed once daily at bedtime and have robust clinical evidence for slowing myopia progression by 50–60%. Unlike higher concentrations used historically, low-dose atropine causes minimal side effects — little to no pupil dilation, light sensitivity, or near blur. Atropine is often used as a standalone treatment in younger children not yet ready for contact lenses, or in combination with Ortho-K for patients with rapid progression.
Myopia Control Spectacle Lenses
For patients who are not yet ready for contact lenses or atropine, specialised spectacle lenses designed for myopia control — such as Essilor Stellest and DIMS (Defocus Incorporated Multiple Segments) lenses — are now available and provide meaningful slowing of progression while correcting vision through conventional glasses wear.
Lifestyle and Environmental Guidance
Evidence strongly supports at least 90 minutes of outdoor time per day as a protective factor against myopia onset and progression. Dr. Zhao provides personalised guidance on screen habits, reading distance, lighting, and outdoor activity as part of every myopia management plan.
How We Monitor Myopia Progression
Effective myopia management requires regular monitoring to track whether treatment is working and adjust the plan as needed. At Amwell Eye Care, Dr. Zhao uses:
- Axial length measurement — the definitive measure of myopia progression; tracking eye length over time is more precise than prescription changes alone
- Cycloplegic refraction — accurate prescription measurement under cycloplegia removes the influence of accommodation, giving a true picture of the underlying myopia
- Corneal topography — essential for Ortho-K fitting, monitoring corneal shape response, and detecting any contact lens-related changes
- 6-monthly review appointments — progression is tracked at every visit and treatment is escalated if the current approach is not adequately controlling growth
Who Is a Candidate for Myopia Management?
Dr. Zhao recommends discussing myopia management for any child who:
- Has been diagnosed with myopia, especially before age 12
- Has one or both myopic parents
- Has shown more than -0.50D of progression in the past 12 months
- Is already at -3.00D or higher and still progressing
- Spends significant time on screens or near work with limited outdoor activity
Adults with progressing myopia may also benefit from certain management strategies. Dr. Zhao will assess each patient individually and discuss realistic expectations for slowing progression at any age.
Insurance & Scheduling
Myopia management consultations and monitoring visits are covered under most vision insurance plans. Specialty contact lenses (Ortho-K, MiSight) and atropine drops involve additional costs that vary by treatment; our staff will outline all fees clearly before beginning any program. We accept VSP, EyeMed, Aetna, Blue Cross Blue Shield, and most major plans.
To schedule a myopia management consultation in Hillsborough, NJ, contact us online or call (908) 336-3886. Same-week appointments are often available.
Schedule a Myopia Management Consultation Today
The earlier myopia management begins, the greater the impact on your child’s long-term vision and eye health. Don’t wait for the prescription to get worse.
